A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA.
The list price runs about $477,000 a year but patients' out-of-pocket costs will vary based on insurance coverage and eligibility for financial https://t.co/GQvBuPXhX4
The list price runs about $477,000 a year but patients' out-of-pocket costs will vary based on insurance coverage and eligibility for financial https://t.co/GQvBuPXhX4

2
